Resources
Filter by Topic
- Blogs
As the demands on real-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the...
- Blogs
Health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE) teams are under growing pressure to deliver meaningful insights faster than ever before. As...
- Blogs
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
- Blogs
By Stacy Justo, Meghana Shamsunder, and Marten van den Berg
- Blogs
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build...
- Blogs
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization...
- Press Releases
Embed validated patient phenotype definitions directly into your workflow for faster insights
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
Linking Real-World Data is Like Making a Fine, Blended Wine
In the healthcare and life sciences industries, developments like the explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization